CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemiaLixiazi He(Heidelberg University), Caroline Pabst(European Molecular Biology Organization)EMBO Molecular MedicineMarch 7, 202210.15252/emmm.202114990Cited by 21SaveCiteExport RISWatch citationsRelated PapersGPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo|Blood|2016|234Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1|Blood|2022|100